Optos opted in to the Science Museum

Article

Optos will be appearing in an exhibition at the Science Museum in London this month.

Optos will be appearing in an exhibition at the Science Museum in London this month.

The retina device company will play a part in the Make it in Great Britain campaign from 24 July until 9 September this year. The initiative aims to eradicate the assumption that Britain doesn't get involved in the manufacturing aspects of business.

Optos CEO, Roy Davis, exclaimed, “It’s fantastic to see our exhibit representing the British manufacturing industry in the Science Museum alongside iconic companies like McLaren, Airbus, The Royal Mint and Sunseeker, as well as leading small and medium businesses like Ultra Global."

“We’re passionate about UK manufacturing, and we hope that through this exhibition people will realise what a vibrant manufacturing industry we have that we can be proud of. The exhibition is free and we’d encourage people from Scotland to come along and find us here.”

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.